FindTrial
Sign In

Compared of nebulized Dexmedetomidine and nebulised midazolam as premediction for brain MRI

Comparison of nebulized Dexmedetomidine and nebulized Midazolam as premediction for brain MRI in children with developmental delay prospective randomised control double blind trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/02/080928
Enrollment
90
Registered
2025-02-19
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F79- Unspecified intellectual disabilities

Interventions

Intervention1: Nebulization dexmedetomidine 1microgm per kg.: Comparison of nebulised dexmedetomidine and nebulised midazolam as premedication for assessing parental separation and ease of venepunctur

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Children with developmental delay for brain MRI

Exclusion criteria

Exclusion criteria: ASA 4,5 Age less than 2 and more than 12 Recent respiratory infection and cardiac disease Emergency MRI BMI more than 35 Parental refusal

Design outcomes

Primary

MeasureTime frame
Parental separation anxiety score.Timepoint: 30 minutes after nebulization, at receiving child for induction of anesthesia.—

Secondary

MeasureTime frame
Ease of venepuncture Total dose of propofol Hemodynamic profile Recovery profileTimepoint: 30 minutes After MRI—

Countries

India

Contacts

Public ContactDr Tanushree Mohan

Sree Chitra Tirunal Institute of medical Sciences and Technology

smita_vimala@yahoo.com9447699245

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026